BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1688 related articles for article (PubMed ID: 8652532)

  • 21. Preparation and characterization of a 5'-deazaFAD T491V NADPH-cytochrome P450 reductase.
    Zhang H; Gruenke L; Saribas AS; Im SC; Shen AL; Kasper CB; Waskell L
    Biochemistry; 2003 Jun; 42(22):6804-13. PubMed ID: 12779335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the FAD binding domain of cytochrome P450 reductase.
    Hodgson AV; Strobel HW
    Arch Biochem Biophys; 1996 Jan; 325(1):99-106. PubMed ID: 8554349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Redox properties of the isolated flavin mononucleotide- and flavin adenine dinucleotide-binding domains of neuronal nitric oxide synthase.
    Garnaud PE; Koetsier M; Ost TW; Daff S
    Biochemistry; 2004 Aug; 43(34):11035-44. PubMed ID: 15323562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Probing electron transfer in flavocytochrome P-450 BM3 and its component domains.
    Munro AW; Daff S; Coggins JR; Lindsay JG; Chapman SK
    Eur J Biochem; 1996 Jul; 239(2):403-9. PubMed ID: 8706747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interflavin one-electron transfer in the inducible nitric oxide synthase reductase domain and NADPH-cytochrome P450 reductase.
    Yamamoto K; Kimura S; Shiro Y; Iyanagi T
    Arch Biochem Biophys; 2005 Aug; 440(1):65-78. PubMed ID: 16009330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Four crystal structures of the 60 kDa flavoprotein monomer of the sulfite reductase indicate a disordered flavodoxin-like module.
    Gruez A; Pignol D; Zeghouf M; Covès J; Fontecave M; Ferrer JL; Fontecilla-Camps JC
    J Mol Biol; 2000 May; 299(1):199-212. PubMed ID: 10860732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Domain-domain interaction in cytochrome P450BM-3.
    Sevrioukova I; Peterson JA
    Biochimie; 1996; 78(8-9):744-51. PubMed ID: 9010603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The interaction of NADPH-P450 reductase with P450: an electrochemical study of the role of the flavin mononucleotide-binding domain.
    Estabrook RW; Shet MS; Fisher CW; Jenkins CM; Waterman MR
    Arch Biochem Biophys; 1996 Sep; 333(1):308-15. PubMed ID: 8806785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Critical residues involved in FMN binding and catalytic activity in cytochrome P450BM-3.
    Klein ML; Fulco AJ
    J Biol Chem; 1993 Apr; 268(10):7553-61. PubMed ID: 8463285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Affinity isolation and characterization of cytochrome P450 102 (BM-3) from barbiturate-induced Bacillus megaterium.
    Black SD; Linger MH; Freck LC; Kazemi S; Galbraith JA
    Arch Biochem Biophys; 1994 Apr; 310(1):126-33. PubMed ID: 8161195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flavin-binding and protein structural integrity studies on NADPH-cytochrome P450 reductase are consistent with the presence of distinct domains.
    Narayanasami R; Horowitz PM; Masters BS
    Arch Biochem Biophys; 1995 Jan; 316(1):267-74. PubMed ID: 7840627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ferredoxin-dependent iron-sulfur flavoprotein glutamate synthase (GlsF) from the Cyanobacterium synechocystis sp. PCC 6803: expression and assembly in Escherichia coli.
    Navarro F; Martín-Figueroa E; Candau P; Florencio FJ
    Arch Biochem Biophys; 2000 Jul; 379(2):267-76. PubMed ID: 10898944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A second FMN binding site in yeast NADPH-cytochrome P450 reductase suggests a mechanism of electron transfer by diflavin reductases.
    Lamb DC; Kim Y; Yermalitskaya LV; Yermalitsky VN; Lepesheva GI; Kelly SL; Waterman MR; Podust LM
    Structure; 2006 Jan; 14(1):51-61. PubMed ID: 16407065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of the redox properties of human NADPH-cytochrome P450 reductase.
    Munro AW; Noble MA; Robledo L; Daff SN; Chapman SK
    Biochemistry; 2001 Feb; 40(7):1956-63. PubMed ID: 11329262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spectroscopic and kinetic properties of a recombinant form of the flavin domain of spinach NADH: nitrate reductase.
    Quinn GB; Trimboli AJ; Prosser IM; Barber MJ
    Arch Biochem Biophys; 1996 Mar; 327(1):151-60. PubMed ID: 8615685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterologous expression of an endogenous rat cytochrome b(5)/cytochrome b(5) reductase fusion protein: identification of histidines 62 and 85 as the heme axial ligands.
    Davis CA; Dhawan IK; Johnson MK; Barber MJ
    Arch Biochem Biophys; 2002 Apr; 400(1):63-75. PubMed ID: 11913972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spectroscopic properties of Escherichia coli UDP-N-acetylenolpyruvylglucosamine reductase.
    Axley MJ; Fairman R; Yanchunas J; Villafranca JJ; Robertson JG
    Biochemistry; 1997 Jan; 36(4):812-22. PubMed ID: 9020779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The flavin reductase activity of the flavoprotein component of sulfite reductase from Escherichia coli. A new model for the protein structure.
    Eschenbrenner M; Covès J; Fontecave M
    J Biol Chem; 1995 Sep; 270(35):20550-5. PubMed ID: 7657631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of C415 mutants of neuronal nitric oxide synthase.
    Richards MK; Clague MJ; Marletta MA
    Biochemistry; 1996 Jun; 35(24):7772-80. PubMed ID: 8672477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crystal structure of Escherichia coli thioredoxin reductase refined at 2 A resolution. Implications for a large conformational change during catalysis.
    Waksman G; Krishna TS; Williams CH; Kuriyan J
    J Mol Biol; 1994 Feb; 236(3):800-16. PubMed ID: 8114095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 85.